1. Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy 2017; 49(4): 378-97.
2. Kim YJ, Hwang K-C, Kim SW, Lee YC. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia. Int J Med Sci 2018; 15(6): 610-16.
3. Cho S-J, Choi I, Kim C, Lee J, Kook M-C, Park S, et al. Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification. Endoscopy 2011; 43(6): 465-71.
4. Choi CW, Kim HW, Shin DH, Kang DH, Hong YM, Park JH, et al. The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia). Dig Dis Sci 2014; 59(2): 421-7.
5. De Vries AC, Haringsma J, Kuipers E. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12(1): 1-15.
6. Lemmens B, Arijs I, Van Assche G, Sagaert X, Geboes K, Ferrante M, et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis 2013; 19(6): 1194-201.
7. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, et al. A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency. Am J Gastroenterol 2016; 111(10): 1467-75.
8. Jemilohun AC, Otegbayo JA, Ola SO, Oluwasola OA, Akere A. Prevalence of Helicobacter pylori among Nigerian patients with dyspepsia in Ibadan. Pan Afr Med J 2010; 6: 18.
9. Bergholt MS, Zheng W, Lin K, Ho KY, Teh M, Yeoh KG, et al. Raman endoscopy for in vivo differentiation between benign and malignant ulcers in the stomach. Analyst 2010; 135(12): 3162-8.
10. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018; 10: 239-48.
11. Yoshida H, Shimazu T, Kiyuna T, Marugame A, Yamashita Y, Cosatto E, et al. Automated histological classification of whole-slide images of gastric biopsy specimens. Gastric Cancer. 2018;21(2):249-57.
12. Kubota-Aizawa S, Ohno K, Fukushima K, Kanemoto H, Nakashima K, Uchida K, et al. Epidemiological study of gastric Helicobacter spp. in dogs with gastrointestinal disease in Japan and diversity of Helicobacter heilmannii sensu stricto. Vet J 2017; 225: 56-62.
13. Bilman FB, Özdemir M, Baysal B, Kurtoğlu MG. Prevalence of H. pylori in gastric biopsy specimen in the southeastern region of Turkey. J Infect Dev Ctries 2016; 10(11): 1177-82.
14. van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016; 388(10060): 2654-64.
15. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol 2020; 18(3): 534-42.
16. Sonnenberg A, Genta RM. Prevalence of benign gastric polyps in a large pathology database. Dig Liver Dis 2015; 47(2): 164-9.
17. Song H, Ekheden IG, Zheng Z, Ericsson J, Nyrén O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 2015; 351: h3867.
18. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010; 139(6): 1894-901. e2.
19. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55(11): 1545-52.
20. Zhang C, Yamada N, Wu Y-L, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005; 11(6): 791-6.
21. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006; 15(6): 1083-94.
22. Raghavendra RS. Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS 2012; 16(3): 360-72.
Velázquez-Dohorn ME, López-Durand CF, Gamboa-Domínguez A. Changing trends in gastric polyps. Rev Invest Clin 2018; 70(1): 40-5.